Analystreport

Acorda Therapeutics Inc (NASDAQ: ACOR) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors